REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING
FIRM

To the shareholders and the Board of Trustees of Brighthouse
Funds Trust II

In planning and performing our audits of the financial
statements of Brighthouse Funds Trust II (the "Fund"),
including the Baillie Gifford International Stock Portfolio,
BlackRock Bond Income Portfolio, BlackRock Capital
Appreciation Portfolio, BlackRock Ultra-Short Term Bond
Portfolio, Brighthouse Asset Allocation 20 Portfolio,
Brighthouse Asset Allocation 40 Portfolio, Brighthouse Asset
Allocation 60 Portfolio, Brighthouse Asset Allocation 80
Portfolio, Brighthouse/Artisan Mid Cap Value Portfolio,
Brighthouse/Dimensional International Small Company
Portfolio, Brighthouse/Wellington Balanced Portfolio,
Brighthouse/Wellington Core Equity Opportunities Portfolio,
Frontier Mid Cap Growth Portfolio, Jennison Growth
Portfolio, Loomis Sayles Small Cap Core Portfolio, Loomis
Sayles Small Cap Growth Portfolio, MetLife Aggregate
Bond Index Portfolio, MetLife Mid Cap Stock Index
Portfolio, MetLife MSCI EAFE Index Portfolio, MetLife
Russell 2000 Index Portfolio, MetLife Stock Index Portfolio,
MFS Total Return Portfolio, MFS Value Portfolio,
Neuberger Berman Genesis Portfolio, T. Rowe Price Large
Cap Growth Portfolio, T. Rowe Price Small Cap Growth
Portfolio, Van Eck Global Natural Resources Portfolio,
Western Asset Management Strategic Bond Opportunities
Portfolio, and Western Asset Management U.S. Government
Portfolio, as of and for the year ended December 31, 2019, in
accordance with the standards of the Public Company
Accounting Oversight Board (United States) (PCAOB), we
considered the Fund's internal control over financial
reporting, including controls over safeguarding securities, as
a basis for designing our auditing procedures for the purpose
of expressing our opinion on the financial statements and to
comply with the requirements of Form N-CEN, but not for
the purpose of expressing an opinion on the effectiveness of
the Fund's internal control over financial reporting.
Accordingly, we express no such opinion.

The management of the Fund is responsible for establishing
and maintaining effective internal control over financial
reporting. In fulfilling this responsibility, estimates and
judgments by management are required to assess the
expected benefits and related costs of controls. A fund's
internal control over financial reporting is a process designed
to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted
accounting principles. A fund's internal control over
financial reporting includes those policies and procedures
that (1) pertain to the maintenance of records that, in
reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the fund; (2)
provide reasonable assurance that transactions are recorded
as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles,
and that receipts and expenditures of the fund are being made
only in accordance with authorizations of management and
trustees of the fund; and (3) provide reasonable assurance
regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of a fund's assets that could
have a material effect on the financial statements.

Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.

A deficiency in internal control over financial reporting
exists when the design or operation of a control does not
allow management or employees, in the normal course of
performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a
deficiency, or a combination of deficiencies, in internal
control over financial reporting, such that there is a
reasonable possibility that a material misstatement of the
fund's annual or interim financial statements will not be
prevented or detected on a timely basis.

Our consideration of the Fund's internal control over
financial reporting was for the limited purpose described in
the first paragraph and would not necessarily disclose all
deficiencies in internal control that might be material
weaknesses under standards established by the PCAOB.
However, we noted no deficiencies in the Fund's internal
control over financial reporting and its operation, including
controls for safeguarding securities, that we consider to be a
material weakness, as defined above, as of December 31,
2019.

This report is intended solely for the information and use of
management and the Board of Trustees of the Fund and the
Securities and Exchange Commission and is not intended to
be and should not be used by anyone other than these
specified parties.

/s/ Deloitte & Touche LLP

Boston, Massachusetts
February 24, 2020